390.8000 0.40 (0.10%)
NSE Dec 30, 2025 14:08 PM
Volume: 1.7M
 

logo
Biocon Ltd.
12 Nov 2024
390.80
0.10%
Sharekhan
Revenues stood at Rs. 3,590 crore, up 4% y-o-y and a 5% rise q-o-q. EBITDA reached Rs. 730 crore, down 1% y-o-y but up 24% q-o-q. PAT stood at Rs. 27 crore, a decline of 84% y-o-y and 97% q-o-q.
ICICI Direct downgraded Biocon Ltd. to Sell with a price target of 350.0 on 10 Dec, 2025.
More from Biocon Ltd.
Recommended